Molecular pathology of primary intraocular lymphoma

Transactions of the American Ophthalmological Society

Volumn 101, Issue , 2003, Pages 275-292

  Chan, Chi Chao ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD68 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; CYTOKINE; DNA; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; INTERLEUKIN 10; INTERLEUKIN 6; MESSENGER RNA; VIRUS DNA;

AUTORADIOGRAPHY; B CELL LYMPHOMA; COMPLEMENTARITY DETERMINING REGION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; GENE REARRANGEMENT; HUMAN; HUMAN HERPESVIRUS 8; HUMAN TISSUE; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOHISTOCHEMISTRY; INTRAOCULAR TUMOR; MAJOR CLINICAL STUDY; MICRODISSECTION; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; TOXOPLASMA GONDII;

ANIMALS; CYTOKINES; DNA, PROTOZOAN; DNA, VIRAL; EYE NEOPLASMS; GENE REARRANGEMENT; HERPESVIRUS 4, HUMAN; HERPESVIRUS 8, HUMAN; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; INTERLEUKIN-10; INTERLEUKIN-6; LYMPHOMA, B-CELL; MICRODISSECTION; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR4; RECEPTORS, CYTOKINE; RNA, MESSENGER; TOXOPLASMA; VITREOUS BODY;

EID: 1142286530     PISSN: 00659533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (150)

1. Qualman SL, Mendelsohn G, Mann RB, et al. Intraocular lymphomas. Natural history based on a clinicopathologic study of eight cases and review of the literature. Cancer 1983;52:878-886.
2. Buggage RR, Chan CC, Nussenblatt RB. Ocular manifestations of central nervous system lymphoma. Curr Opin Oncol 2001;13:137-142.
3. Whiteup SM, de Smet MD, Rubin BI, et al. Intraocular lymphoma. Clinical and histopathologic diagnosis. Ophthalmology 1993;100:1399-1406.
4. Bataille B, Delwail V, Menet E, et al. Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg 2000;92:261-266.
5. Paulus W. Classification, pathogenesis and molecular pathology of primary CNS lymphomas. J Neurooncol 1999;43:203-208.
6. Nelson CC, Hertzberg BS, Klintworth GK. A histopathologic study of 716 unselected eyes in patients with cancer at the time of death. Am J Ophthalmol 1983;95:788-793.
7. Rattray KM, Cole MD, Smith SR. Systemic non-Hodgkin's lymphoma presenting as a serpiginous choroidopathy: report of a case and review of the literature. Eye 2000;14(pt 5):706-710.
8. Cooper EL, Ricker JL. Malignant lymphoma of the uveal tract. Am J Ophthalmol 1951;34:1153-1158.
9. Vogel MH, Font RL, Zimmerman LE, et al. Reticulum cell sarcoma of the retina and uvea. Report of six cases and review of the literature. Am J Ophthalmol 1968;66:205-215.
10. Kaplan HJ, Meredith TA, Aaberg TM, et al. Reclassification of intraocular reticulum cell sarcoma (histiocytic lymphoma). Immunologic characterization of vitreous cells. Arch Ophthalmol 1980;98:707-710.
11. Schabet M. Epidemiology of primary CNS lymphoma. J Neurooncol 1999;43:199-201.
12. Eby NL, Grufferman S, Flannelly CM, et al. Increasing incidence of primary brain lymphoma in the US. Cancer 1988;62:2461-2465.
13. Thomas JO. Acquired immunodeficiency syndrome-associated cancers in Sub-Saharan Africa. Semin Oncol 2001;28:198-206.
14. Nasir S, DeAngelis LM. Update on the management of primary CNS lymphoma. Oncology (Huntington) 2000;14:228-234.
15. DeAngelis LM. Brain tumors. N Engl J Med 2001;344:114-123.
16. Corn BW, Marcus SM, Topham A, et al. Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000? Cancer 1997;79:2409-2413.
17. Peterson K, Gordon KB, Heinemann MH, et al. The clinical spectrum of ocular lymphoma. Cancer 1993;72:843-849.
18. Cassoux N, Merle-Beral H, Leblond V, et al. Ocular and central nervous system lymphoma: clinical features and diagnosis. Ocul Immunol Inflamm 2000;8:243-250.
19. Akpek EK, Ahmed I, Hochberg FH, et al. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes. Ophthalmology 1999;106:1805-1810.
20. Siegel MJ, Dalton J, Friedman AH, et al. Ten-year experience with primary ocular 'reticulum cell sarcoma' (large cell non-Hodgkin's lymphoma). Br J Ophthalmol 1989;73:342-346.
21. Ursea R, Heinemann MH, Silverman RH, et al. Ophthalmic, ultrasonographic findings in primary central nervous system lymphoma with ocular involvement. Retina 1997;17:118-123.
22. Matsuo T, Yamaoka A, Shiraga F, et al. Two types of initial ocular manifestations in intraocular-central nervous system lymphoma. Retina 1998;18:301-307.
23. Velez G, de Smet MD, Whitcup SM, et al. Iris involvement in primary intraocular lymphoma: report of two cases and review of the literature. Surv Ophthalmol 2000;44:518-526.
24. Rothova A, Ooijman F, Kerkhoff F, et al. Uveitis masquerade syndromes. Ophthalmology 2001;108:386-399.
25. Gill MK, Jampol LM. Variations in the presentation of primary intraocular lymphoma: case reports and a review. Surv Ophthalmol 2001;45:463-471.
26. Merchant A, Foster CS. Primary intraocular lymphoma. Int Ophthalmol Clin 1997;37:101-115.
27. Ridley ME, McDonald HR, Sternberg P Jr, et al. Retinal manifestations of ocular lymphoma (reticulum cell sarcoma). Ophthalmology 1992;99:1153-1160.
28. Dean JM, Novak MA, Chan CC, et al. Tumor detachments of the retinal pigment epithelium in ocular/central nervous system lymphoma. Retina 1996;16:47-56.
29. Herrlinger U. Primary CNS lymphoma: findings outside the brain. J Neurooncol 1999;43:227-230.
30. Davis JW, Moriarty RP, Schlossberg SM, et al. Bilateral testicular lymphoma treated with chemotherapy and radiation without orchiectomy: complete response relapsed at 52 months in the vitreous humor. Urology 2001;57:555.
31. Herrlinger U, Schabet M, Bitzer M, et al. Primary central nervous system lymphoma: from clinical presentation to diagnosis. J Neurooncol 1999;43:219-226.
32. Ciricillo SF, Rosenblum ML. Use of CT and MR imaging to distinguish intracranial lesions and to define the need for biopsy in AIDS patients. J Neurosurg 1990;73:720-724.
33. Davis JL, Solomon D, Nussenblatt RB, et al. Immunocytochemical staining of vitreous cells. Indications, techniques, and results. Ophthalmology 1992;99:250-256.
34. Whitcup SM, Chan CC, Buggage RR, et al. Improving the diagnostic yield of vitrectomy for intraocular lymphoma [letter; comment]. Arch Ophthalmol 2000;118:446.
35. Barr CC, Green WR, Payne JW, et al. Intraocular reticulum-cell sarcoma: clinico-pathologic study of four cases and review of the literature. Surv Ophthalmol 1975;19:224-239.
36. Matsuo K, Nakatuka K, Matsuura T, et al. Primary intraocular lymphoma mimicking late postoperative endophthalmitis. Ophthalmologica 1995;209:331-335.
37. Kirmani MH, Thomas EL, Rao NA, et al. Intraocular reticulum cell sarcoma: diagnosis by choroidal biopsy. Br J Ophthalmol 1987;71:748-752.
38. Lopez JS, Chan CC, Burnier M, et al. Immunohistochemistry findings in primary intraocular lymphoma. Am J Ophthalmol 1991;112:472-474.
39. Lefebvre A, Candaele C, Verbraeken H, et al. Choroidal biopsy in the diagnosis of a suspect intraocular lesions. Bull Soc Belge Ophtalmol 1995;255:93-97.
40. Buggage RR, Velez G, Myers-Powell B, et al. Primary intraocular lymphoma with a low interleukin 10 to interleukin 6 ratio and heterogeneous IgH gene rearrangement. Arch Ophthalmol 1999;117:1239-1242.
41. Shields JA, Shields CL, Ehya H, et al. Fine-needle aspiration biopsy of suspected intraocular tumors. The 1992 Urwick Lecture. Ophthalmology 1993;100:1677-1684.
42. Fyrat P, Mocan G. Lymphoma presenting as a solitary mass: diagnosis by fine needle aspiration biopsy. Cytopathology 2000;11:276-278.
43. Levy-Clarke GA, Byrnes GA, Buggage RR, et al. Primary intraocular lymphoma diagnosed by fine needle aspiration biopsy of a subretinal lesion. Retina 2001;21:281-284.
44. Wilson DJ, Braziel R, Rosenbaum JT. Intraocular lymphoma. Immunopathologic analysis of vitreous biopsy specimens. Arch Ophthalmol 1992;110:1455-1458.
45. Davis JL, Viciana AL, Ruiz P. Diagnosis of intraocular lymphoma by flow cytometry. Am J Ophthalmol 1997;124:362-372.
46. Trainor KJ, Brisco MJ, Story CJ, et al. Monoclonality in B-lymphoproliferative disorders detected at the DNA level. Blood 1990;75:2220-2222.
47. Linke B, Bolz I, Fayyazi A, et al. Automated high resolution PCR fragment analysis for identification of clonally rearranged immunoglobulin heavy chain genes. Leukemia 1997;11:1055-1062.
48. Shen DF, Zhuang Z, LeHoang P, et al. Utility of microdissection and polymerase chain reaction for the detection of immunoglobulin gene rearrangement and translocation in primary intraocular lymphoma. Ophthalmology 1998;105:1664-1669.
49. Tuaillon N, Chan CC. Molecular analysis of primary central nervous system and primary intraocular lymphoma. Curr Mol Med 2001;1:259-1272.
50. Benjamin D, Park CD, Sharma V. Human B cell interleukin 10. Leuk Lymphoma 1994;12:205-210.
51. Cortes J, Kurzrock R. Interleukin-10 in non-Hodgkin's lymphoma. Leuk Lymphoma 1997;26:251-259.
52. Fassone L, Gaidano G, Ariatti C, et al. The role of cytokines in the pathogenesis and management of AIDS-related lymphomas. Leuk Lymphoma 2000;38:481-488.
53. Khatri VP, Caligiuri MA. A review of the association between interleukin-10 and human B-cell malignancies. Cancer Immunol Immunother 1998;46:239-244.
54. Banchereau J, Briere F, Liu YJ, et al. Molecular control of B lymphocyte growth and differentiation. Stem Cells 1994;12:278-288.
55. Chan CC, Whiteup SM, Solomon D, et al. Interleukin-10 in the vitreous of primary intraocular lymphoma. Am J Ophthalmol 1995;120:671-673.
56. Whitcup SM, Stark-Vanes V, Wittes RE, et al. Association of interleukin-10 in the vitreous and cerebral spinal fluid and primary central nervous system lymphoma. Arch Ophthalmol 1997;115:1157-1160.
57. Tritten JJ, Haefliger JM, Delouche D, et al. [Interleukin 10 and chronic vitritis in a case of ocular lymphoma]. Klin Monatsbl Augenheilkd 1998;212:416-417.
58. Akpek EK, Maca SM, Christen WG, et al. Elevated vitreous interleukin-10 level is not diagnostic of intraocular-central nervous system lymphoma. Ophthalmology 1999;106:2291-2295.
59. Michelson JB, Michelson PE, Bordin GM, et al. Ocular reticulum cell sarcoma. Presentation as retinal detachment with demonstration of monoclonal immunoglobulin light chains on the vitreous cells. Arch Ophthalmol 1981;99:1409-1411.
60. Chan CC, Shen D, Nussenblatt RB, et al. Detection of molecular changes in primary intraocular lymphoma by microdissection and polymerase chain reaction [letter]. Diagn Mol Pathol 1998;7:63-64.
61. White VA, Gascoyne RD, Paton KE. Use of the polymerase chain reaction to detect B- and T-cell gene rearrangements in vitreous specimens from patients with intraocular lymphoma. Arch Ophthalmol 1999;117:761-765.
62. Yunis JJ, Mayer MG, Arnesen MA, et al. bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma [see comments]. N Engl J Med 1989;320:1047-1054.
63. Hill ME, MacLennan KA, Cunningham DC, et al. Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation Study. Blood 1996;88:1046-1051.
64. Hermine O, Haioun C, Lepage E, et al. Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA). Blood 1996;87:265-272.
65. Epstein MA. Epstein-Barr virus-discovery, properties and relationship to nasopharyngeal carcinoma. IARC Sci Publ 1978;20:333-345.
66. Burkitt DP. The discovery of Burkitt's lymphoma. Cancer 1983;51:1777-1786.
67. Harrington DS, Weisenburger DD, Purtilo DT. Epstein-Barr virus-associated lymphoproliferative lesions. Clin Lab Med 1988;8:97-118.
68. Lyons SF, Liebowitz DN. The roles of human viruses in the pathogenesis of lymphoma. Semin Oncol 1998;25:461-475.
69. Otsuki T, Kumar S, Ensoli B, et al. Detection of HHV-8/KSHV DNA sequences in AIDS-associated extranodal lymphoid malignancies. Leukemia 1996;10:1358-1362.
70. Corboy JR, Garl PJ, Kleinschmidt-DeMasters BK. Human herpesvirus 8 DNA in CNS lymphomas from patients with and without AIDS. Neurology 1998;50:335-340.
71. Bashir R, Luka J, Cheloha K, et al. Expression of Epstein-Barr virus proteins in primary CNS lymphoma in AIDS patients. Neurology 1993;43:2358-2362.
72. Itoyama T, Sadamori N, Tsutsumi K, et al. Primary central nervous system lymphomas. Immunophenotypic, virologie, and cytogenetic findings of three patients without immune defects. Cancer 1994;73:455-463.
73. Chan CC, Shen DF, Whitcup SM, et al. Detection of human herpesvirus-8 and Epstein-Barr virus DNA in primary intraocular lymphoma. Blood 1999;93:2749-2751.
74. Shen DF, Herbort CP, Tuaillon N, et al. Detection of Toxoplasma gondii DNA in primary intraocular b-cell lymphoma. Mod Pathol 2001;14:995-999.
75. Schultz C, Scott C, Sherman W, et al. Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06. J Clin Oncol 1996;14:556-564.
76. DeAngelis LM. Primary CNS lymphoma: treatment with combined chemotherapy and radiotherapy. J Neurooncol 1999;43:249-257.
77. Hiraga S, Arita N, Ohnishi T, et al. Rapid infusion of high-dose methotrexate resulting in enhanced penetration into cerebrospinal fluid and intensified tumor response in primary central nervous system lymphomas. J Neurosurg 1999;91:221-230.
78. Blay JY, Ongolo-Zogo P, Sebban C, et al. Primary cerebral lymphomas: unsolved issues regarding first-line treatment, follow-up, late neurological toxicity and treatment of relapses. The FNCLCC. French Federation Nationale des Centres de Lutte contre le Cancer. Ann Oncol 2000;11:39-44.
79. de Smet MD, Vancs VS, Kohler D, et al. Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma. Br J Ophthalmol 1999;83:448-451.
80. Fishburne BC, Wilson DJ, Rosenbaum JT, et al. Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma. Arch Ophthalmol 1997;115:1152-1156.
81. Henson JW, Yang J, Batchelor T. Intraocular methotrexate level after high-dose intravenous infusion. J Clin Oncol 1999;17:1329.
82. de Smet MD. Management of non Hodgkin's intraocular lymphoma with intravitreal methotrexate. Bull Soc Belge Ophtalmol 2001;279:91-95.
83. Soussain C, Suzan F, Hoang-Xuan K, et al. Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma. J Clin Oncol 2001;19:742-749.
84. Zhuang Z, Bertheau P, Emmert-Buck MR, et al. A microdissection technique for archival DNA analysis of specific cell populations in lesions <1 mm in size. Am J Pathol 1995;146:620-625.
85. Emmert-Buck MR, Bonner RF, Smith PD, et al. Laser capture microdissection. Science 1996;274:998-1001.
86. Early P, Huang H, Davis M, et al. An immunoglobulin heavy chain variable region gene is generated from three segments of DNA: VH, D and JH. Cell 1980;19:981-992.
87. Tonegawa S. Somatic generation of antibody diversity. Nature 1983;302:575-581.
88. French DL, Laskov R, Scharff MD. The role of somatic hypermutation in the generation of antibody diversity. Science 1989;244:1152-1157.
89. Chen Y-T, Whitney KD, Chen Y. Clonality analysis of B-cell lymphoma in fresh-frozen and paraffin-embedded tissues: the effects of variable polymerase chain reaction parameters. Mod Pathol 1994;7:429-434.
90. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;268:1895-1869.
91. Wright CF, Reid AH, Tsai MM, et al. Detection of Epstein-Barr virus sequences in Hodgkin's disease by the polymerase chain reaction. Am J Pathol 1991;139:393-398.
92. Burg JL, Grover CM, Pouletty P, et al. Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J Clin Microbiol 1989;27:1787-1792.
93. Vieira P, de Waal-Malefyt R, Dang MN, et al. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc Natl Acad Sci U S A 1991;88:1172-1176.
94. Chan CC, Shen DF. Newer methodologies in immunohistochemistry and diagnosis. In: BenEzra D, ed. Uveitis Update. Basel, Switzerland: Karger; 1999:1-13.
95. Gunn MD, Ngo VN, Ansel KM, et al. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 1998;391:799-803.
96. Legler DF, Loetscher M, Roos RS, et al. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J Exp Med 1998;187:655-660.
97. DeAngelis LM, Yahalom J, Thaler HT, et al. Combined modality therapy for primary CNS lymphoma. J Clin Oncol 1992;10:635-643.
98. Liu K, Stern RC, Rogers RT, et al. Diagnosis of hematopoietic processes by fine-needle aspiration in conjunction with flow cytometry: a review of 127 cases. Diagn Cytopathol 2001;24:1-10.
99. Rousset F, Garcia E, Defrance T, et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A 1992;89:1890-1893.
100. Dukers DF, Jaspars LH, Vos W, et al. Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus-positive and -negative cases of Hodgkin's disease. J Pathol 2000;190:143-149.
101. Petersson M, Charo J, Salazar-Onfray F, et al. Constitutive IL-10 production accounts for the high NK sensitivity, low MHC class I expression, and poor transporter associated with antigen processing (TAP)-1/2 function in the prototype NK target YAC-1. J Immunol 1998;161:2099-2105.
102. Salazar-Onfray F. Interleukin-10: a cytokine used by tumors to escape immunosurveillance. Med Oncol 1999;16:86-94.
103. Shen L, Chiang AK, Liu WP, et al. Expression of HLA class I, beta(2)-microglobulin, TAP1 and IL-10 in Epstein-Barr virus-associated nasal NK/T-cell lymphoma: Implications for tumor immune escape mechanism. Int J Cancer 2001;92:692-696.
104. Buggage RR, Whitcup SM, Nussenblatt RB, et al. Using interleukin 10 to interleukin 6 ratio to distinguish primary intraocular lymphoma and uveitis. Invest Ophthalmol Vis Sci 1999;40:2462-2463.
105. Cassoux N, Merle-Beral H, Lehoang P, et al. Interleukin-10 and intraocular-central nervous system lymphoma. Ophthalmology 2001;108:426-427.
106. Velez G, Buggage R. Interleukin-10 and intraocular-central nervous system lymphoma. Ophthalmology 2001;108:427-428.
107. Weaver DT. V(D)J recombination and double-strand break repair. Adv Immunol 1995;58:29-85.
108. Lewis SM, Agard E, Suh S, et al. Cryptic signals and the fidelity of V(D)J joining. Mol Cell Biol 1997;17:3125-3136.
109. Jacob J, Kelsoe G, Rajewsky K, et al. Intraclonal generation of antibody mutants in germinal centres. Nature 1991;354:389-392.
110. Liu YJ, Malisan F, de Bouteiller O, et al. Within germinal centers, isotype switching of immunoglobulin genes occurs after the onset of somatic mutation. Immunity 1996;4:241-250.
111. Lewis SM. The mechanism of V(D)J joining: lessons from molecular, immunological, and comparative analyses. Adv Immunol 1994;56:27-150.
112. Ramasamy I, Brisco M, Morley A. Improved PCR method for detecting monoclonal immunoglobulin heavy chain rearrangement in B cell neoplasms. J Clin Pathol 1992;45:770-775.
113. Zelenetz AD, Chen TT, Levy R. Clonal expansion in follicular lymphoma occurs subsequent to antigenic selection. J Exp Med 1992;176:1137-1148.
114. Matolesy A, Schattner EJ, Knowles DM, et al. Clonal evolution of B cells in transformation from low- to high-grade lymphoma. Eur J Immunol 1999;29:1253-1264.
115. Aarts WM, Bende RJ, Steenbergen EJ, et al. Variable heavy chain gene analysis of follicular lymphomas: correlation between heavy chain isotype expression and somatic mutation load. Blood 2000;95:2922-2929.
116. Bahler DW, Miklos JA, Swerdlow SH. Ongoing Ig gene hypermutation in salivary gland mucosa-associated lymphoid tissue-type lymphomas. Blood 1997;89:3335-3344.
117. Ottensmeier CH, Thompsett AR, Zhu D, et al. Analysis of VH genes in follicular and diffuse lymphoma shows ongoing somatic mutation and multiple isotype transcripts in early disease with changes during disease progression. Blood 1998;91:4292-4299.
118. Nakamura N, Kuze T, Hashimoto Y, et al. Analysis of the immunoglobulin heavy chain gene variable region of 101 cases with peripheral B cell neoplasms and B cell chronic lymphocytic leukemia in the japanese population. Pathol Int 1999;49:595-600.
119. Lossos IS, Tibshirani R, Narasimhan B, et al. The inference of antigen selection on Ig genes. J Immunol 2000;165:5122-5126.
120. Lossos IS, Okada CY, Tibshirani R, et al. Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas. Blood 2000;95:1797-1803.
121. Montesinos-Rongen M, Kuppers R, Schluter D, et al. Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment. Am J Pathol 1999;155:2077-2086.
122. Thompsett AR, Ellison DW, Stevenson FK, et al. V(H) gene sequences from primary central nervous system lymphomas indicate derivation from highly mutated germinal center B cells with ongoing mutational activity. Blood 1999;94:1738-1746.
123. Julien S, Radosavljevic M, Laibouret N, et al. AIDS primary central nervous system lymphoma: molecular analysis of the expressed VH genes and possible implications for lymphomagenesis. J Immunol 1999;162:1551-1558.
124. Liebowitz D. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients. N Engl J Med 1998;338:1413-1421.
125. Cinque P, Brytting M, Vago L, et al. Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet 1993;342:398-401.
126. Bergmann M, Blasius S, Bankfalvi A, et al. Primary non-Hodgkin lymphomas of the CNS-proliferation, oncoproteins and Epstein-Barr-virus. Gen Diagn Pathol 1996;141:235-242.
127. Chang Y, Moore PS. Kaposi's sarcoma (KS)-associated herpesvirus and its role in KS. Infect Agents Dis 1996;5:215-222.
128. Antinori A, Larocca LM, Fassone L, et al. HHV-8/KSHV is not associated with AIDS-related primary central nervous system lymphoma. Brain Pathol 1999;9:199-208.
129. Russo JJ, Bohenzky RA, Chien MC, et al. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A 1996;93:14862-14867.
130. Smit RL, Baarsma GS, de Vries J. Classification of 750 consecutive uveitis patients in the Rotterdam Eye Hospital. Int Ophthalmol 1993;17:71-76.
131. Gilbert RE, Dunn DT, Lightman S, et al. Incidence of symptomatic Toxoplasma eye disease: aetiology and public health implications. Epidemiol Infect 1999;123:283-289.
132. Holland GN, O'Connor GR, Belfort RJ, et al. Toxoplasmosis. In: Pepose JS, Holland GN, Wilhelmus KR, eds. Ocular Infection and Immunity. St Louis, Mo: Mosby; 1996:1183-1224.
133. Stein K, Hummel M, Korbjuhn P, et al. Monocytoid B cells are distinct from splenic marginal zone cells and commonly derive from unmutated naive B cells and less frequently from postgerminal center B cells by polyclonal transformation. Blood 1999;94:2800-2808.
134. Spencer J, Wotherspoon AC. Gastric MALT lymphoma and Helicobacter pylori. Cancer Surv 1997;30:213-231.
135. Bouzourene H, Haefliger T, Delacretaz F, et al. The role of Helicobacter pylori in primary gastric MALT lymphoma. Histopathology 1999;34:118-123.
136. Nakamura S, Aoyagi K, Furuse M, et al. B-cell monoclonality precedes the development of gastric MALT lymphoma in Helicobacter pylori-associated chronic gastritis. Am J Pathol 1998;152:1271-1279.
137. Wotherspoon AC. A critical review of the effect of Helicobacter pylori eradication on gastric MALT lymphoma. Curr Gastroenterol Rep 2000;2:494-498.
138. Walt RP. Regression of MALT lymphoma and treatment for Helicobacter pylori. Lancet 1996;348:1041-1042.
139. Montalban C, Manzanal A, Boixeda D, et al. Helicobacter pylori eradication for the treatment of low-grade gastric MALT lymphoma: follow-up together with sequential molecular studies. Ann Oncol 1997;8:37-39.
140. Martin J, Boyle S, Jacyna M. Regression of a large gastric MALT lymphoma with antibiotic treatment to eradicate Helicobacter pylori. Postgrad Med J 1997;73:109-110.
141. Falco Jover G, Martinez Egea A, Sanchez Cuenca J, et al. Regression of primary gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma after eradication of Helicobacter pylori. Rev Esp Enferm Dig 1999;91:541-548.
142. Miki H, Kobayashi S, Harada H, et al. Early stage gastric MALT lymphoma with high-grade component cured by Helicobacter pylori eradication. J Gastroenterol 2001;36:121-124.
143. de Smet MD, Nussenblatt RB, Davis JL, et al. Large cell lymphoma masquerading as a viral retinitis. Int Ophthalmol 1990;14:413-417.
144. Matzkin DC, Slamovits TL, Rosenbaum PS. Simultaneous intraocular and orbital non-Hodgkin lymphoma in the acquired immune deficiency syndrome. Ophthalmology 1994;101:850-855.
145. Gass JD, Trattler HL. Retinal artery obstruction and atheromas associated with non-Hodgkin's large cell lymphoma (reticulum cell sarcoma). Arch Ophthalmol 1991;109:1134-1139.
146. Jenh CH, Cox MA, Hipkin W, et al. Human b cell-attracting chemokine 1 (bca-1; cxcl13) is an agonist for the human cxcr3 receptor. Cytokine 2001;15:113-121.
147. Nagasawa T, Tachibana K, Kishimoto T. A novel CXC chemokine PBSF/SDF-1 and its receptor CXCR4: their functions in development, hematopoiesis and HIV infection. Semin Immunol 1998;10:179-185.
148. Murdoch C. CXCR4: chemokine receptor extraordinaire. Immunol Rev 2000;177:175-184.
149. Mazzucchelli L, Blaser A, Kappeler A, et al. BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma. J Clin Invest 1999;104:R49-54.
150. Durig J, Schmucker U, Duhrsen U. Differential expression of chemokine receptors in B cell malignancies. Leukemia 2001;15:752-756.